Wednesday, November 14, 2018

Ventricular Assist Devices Market Is Expected To Reach Usd 2.5 billion By The End Of 2025

Industry Trend Analysis
The global ventricular assist devices (VADs) market is projected to be around $2.5 billion by 2025 and it is expected to exhibit a positive growth over the forecast period. Increasing prevalence of cardiovascular diseases such as coronary artery disorders, heart failure and hypertension are the key factors driving the growth of VADs market. Also, rise in aging population and technological advancements in VADsare largely contributing to the positive market growth. As per a report of the Center for Diseases Control and Prevention, about 5.7 million American adults were affected by heart failure in 2016. VADs are being widely used as destination therapies for patients with advanced heart failure. Heart failure prevalence rises with age following an exponential pattern. Some potential risks associated with VADs are blood clots, excessive bleeding during and after procedure and device malfunctions. These factors can hamper the market growth to some extent.
Competitive Outlook and Trend Analysis
The global VADs market is a consolidated market with few large players holding the majority share of the market. The strategy adopted by these players is, acquiring small vendors and growing their product portfolio and market coverage to gain competitive advantage. Some of the major players in VADs market are, Abiomed, Inc., Boston Scientific Corporation, Berlin Heart GmbH, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, ReliantHeart Inc., HeartWare International, Inc., Jarvik Heart, Inc., and St. Jude Medical, Inc.
Regional Outlook and Trend Analysis
In 2016, North America dominated the global VADs market with highest market share. This dominance can be attributed to the presence of huge patient population along with high adoption of technologically advanced products and high disposable income of the population. With the presence of sophisticated healthcare infrastructure the market will show significant growth over the forecast period.
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA
Market Segmentation-
By Product:
Right Ventricular Assist Devices (RVADs)
Left Ventricular Assist Devices (LVADs)
Biventricular Assist Devices (BIVADs)
By Application:
Destination Therapy
BTT and BTD Therapies
BTR Therapy
By Design:
Implantable VADs
Percutaneous VADs
By End User:
Ambulatory Surgical Centers
Hospitals
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Ventricular Assist Devices Market, By Product
5. Ventricular Assist Devices Market, By Application
6. Ventricular Assist Devices Market, By Design
7. Ventricular Assist Devices Market, By End User
8. Ventricular Assist Devices Market, By Region
…….CONTINUED FOR TOC
List of Tables
Table 1.Global Ventricular Assist Devices, By Product ($Million), 2016-2025
Table 2.Left Ventricular Assist Devices Market, By Region ($Million), 2016-2025
Table 3.Right Ventricular Assist Devices Market, By Region ($Million), 2016-2025
Table 4.Biventricular Assist Devices Market, By Region ($Million), 2016-2025
Table 5.Global Ventricular Assist Devices, By Application ($Million), 2016-2025
Table 6.BTT and BTD Therapies Market, By Region ($Million), 2016-2025
Table 7.Destination Therapy Market, By Region ($Million), 2016-2025
List of Figures
Figure 1.Global Ventricular Assist Devices Market Share, By Product, 2016 & 2025
Figure 2.Ventricular Assist Devices Market, By Application, 2016 ($Million)
Figure 3.Ventricular Assist Devices Market, By Design, 2016 ($Million)
Figure 4.Ventricular Assist Devices Market, By End User, 2016 ($Million)
Figure 5.Abiomed, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 6.Abiomed, Inc.: Net Revenue Share, By Segment, 2016
Figure 7.Abiomed, Inc.: Net Revenue Share, By Geography, 2016
To Check an Discount of This Precious Report @
https://www.crystalmarketresearch.com/check-discount/HC0624
About Crystal Market Research:
Crystal Offers One Stop Solution For Market Research, Business Intelligence, And Consulting Services To Help Clients Make More Informed Decisions. It Provides Both Syndicated As Well As Customized Research Studies For Its Customers Spread Across The Globe. The Company Offers Market Intelligence Reports Across A Broad Range Of Industries Including Healthcare, Chemicals & Materials, Technology, Automotive, And Energy.
Contact Us:
Judy S,
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: Sales@Crystalmarketresearch.Com






No comments:

Post a Comment